Stablix
PrivateLast Round
Series A
Jun 3, 2021
Total Funding Raised
$63M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Stablix operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series A round in June 2021.
Stablix is a biotechnology company that develops a drug discovery platform focused on targeted protein stabilization to treat rare diseases, cancer, and immunological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stablix Comparables
Compare Stablix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vicinitas Therapeutics | 89% | |
| Entact Bio | 87% | |
| Atlas Molecular Pharma | 79% |
For institutional investors. Book with your work email.
Stablix Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Stablix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Enterprise Associates | Series A |
| Cormorant Asset Management | Series A |
| Versant Ventures | Series A |
| Cormorant Asset Management | Series A |
| Euclidean Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 43% MoM, reaching 2.5K.
- Jun 3, 2021
$63M round led by Versant Ventures
For institutional investors. Book with your work email.
Stablix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Stablix's valuation, stock price, and market status.
Is Stablix a public or private company?
Stablix is a private company.
What is the current stock price of Stablix?
Stablix is a private company, so its shares have no public market price. Caplight tracks Stablix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Stablix worth (valuation)?
Valuation information for Stablix is not publicly available.
Can I buy Stablix stock?
Stablix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Stablix's last funding round?
Stablix's most recent funding round was Series A on June 3, 2021.
Who are the main investors in Stablix?
Key investors in Stablix include Versant Ventures.
Will Stablix IPO soon?
No public IPO plans have been announced for Stablix.
How can I track Stablix secondary market activity?
Caplight tracks bids, offers, and trades in Stablix's shares on secondary markets.